O-糖基化可以抑制人类小岛粉样蛋白多的聚合和毒性
Qian Zhang1, Xiaohan Mei1, Yan Li1
1State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials of Ministry of Education and College of Life Sciences, Nankai University, Tianjin, China.
Communications biology
|November 6, 2025
概括
一种新型的O-糖基化,SNS,有效地抑制人类小岛粉样蛋白多 (hIAPP) 聚合,保护胰腺β细胞免受2型糖尿病 (T2D) 相关的损伤和功能障碍.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 2型糖尿病 (T2D) 涉及胰腺β细胞衰竭,损害胰岛素生产和葡萄糖调节.
- 聚合的人类小岛粉样多 (hIAPP) 导致β细胞功能障碍和损失.
- 针对hIAPP聚合是T2D的潜在治疗策略.
研究的目的:
- 设计和识别抑制hIAPP纤维化的O-糖基化.
- 评估已识别的对β细胞和小岛功能的保护作用.
主要方法:
- 一个聚焦的O-糖基化的图书馆的设计,以hIAPP单体为目标.
- 选图书馆以确定有效抑制hIAPP纤维化的抑制剂.
- 用类 (SNS) 治疗β细胞和分离的小鼠岛屿.
- 评估hIAPP诱导的氧化应激,细胞毒性和亡.
主要成果:
- 一种N-乙葡萄糖胺修饰,SNS,被确定为hIAPP纤维化的强有力的抑制剂.
- SNS治疗保护了β细胞和保留了小岛功能.
- 在β细胞中,SNS抑制了hIAPP诱导的氧化应激,细胞毒性和亡.
结论:
- O-糖基化体是开发hIAPP对手的有希望的策略.
- SNS证明了缓解T2D中的β细胞衰竭的治疗潜力.
- 这种方法可能会导致针对粉样蛋白相关疾病的新疗法.
更多相关视频
相关概念视频
Glucagon-like Receptor Agonists
828
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
828
Dipeptidyl Peptidase 4 Inhibitors
570
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
570
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Oligosaccharide Assembly
3.5K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.5K
Proteoglycans
4.6K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.6K
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K


